- Home
- LOCO vs ETON Comparison
LOCO vs ETON Comparison
Compare LOCO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- ETON
- Stock Information
- Founded
- LOCO 1980
- ETON 2017
- Country
- LOCO United States
- ETON United States
- Employees
- LOCO N/A
- ETON N/A
- Industry
- LOCO Restaurants
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- ETON Health Care
- Exchange
- LOCO Nasdaq
- ETON Nasdaq
- Market Cap
- LOCO 331.5M
- ETON 388.3M
- IPO Year
- LOCO 2014
- ETON 2018
- Fundamental
- Price
- LOCO $10.96
- ETON $14.85
- Analyst Decision
- LOCO Buy
- ETON Strong Buy
- Analyst Count
- LOCO 3
- ETON 3
- Target Price
- LOCO $15.50
- ETON $29.67
- AVG Volume (30 Days)
- LOCO 347.2K
- ETON 621.3K
- Earning Date
- LOCO 07-31-2025
- ETON 08-07-2025
- Dividend Yield
- LOCO N/A
- ETON N/A
- EPS Growth
- LOCO 6.54
- ETON N/A
- EPS
- LOCO 0.86
- ETON N/A
- Revenue
- LOCO $476,032,000.00
- ETON $48,327,000.00
- Revenue This Year
- LOCO $6.28
- ETON $103.21
- Revenue Next Year
- LOCO $1.14
- ETON $51.34
- P/E Ratio
- LOCO $12.99
- ETON N/A
- Revenue Growth
- LOCO 1.22
- ETON 40.88
- 52 Week Low
- LOCO $8.29
- ETON $3.25
- 52 Week High
- LOCO $14.25
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- LOCO 57.24
- ETON 54.31
- Support Level
- LOCO $10.94
- ETON $13.78
- Resistance Level
- LOCO $11.55
- ETON $16.27
- Average True Range (ATR)
- LOCO 0.40
- ETON 0.83
- MACD
- LOCO -0.02
- ETON 0.32
- Stochastic Oscillator
- LOCO 67.74
- ETON 77.67
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.